Delivery Order SPE2DB22D3004-SPE2DB25FSF16
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $11,154.18 for Lupron Depot-Ped 11.25 mg (a 3-month supply) on September 3, 2025, with ultimate completion by September 4, 2025. This non-set-aside, competitively awarded contract with firm fixed pricing is funded through the Defense Logistics Agency's Medical Supply Chain and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $33,553.93 to AmerisourceBergen Drug Corp for Lupron Depot-Ped 30 mg 3-month kits, a specialty pharmaceutical product used in pediatric endocrinology treatment. This firm fixed-price delivery order, awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,911.29 to AmerisourceBergen Drug Corp for the supply of Lupron Depot-Ped 11.25 mg kits. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 26, 2025. The delivery order will be fulfilled from AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a $17,214.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot-Ped 15 mg kits on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside award was made competitively and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,280.87 for Lupron Depot-PED 30 mg 3-month kits on August 22, 2025, with a completion deadline of August 25, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $5,632.97 to AmerisourceBergen Drug Corp for the supply of Lupron Depot-PED 7.5 mg kits under a firm fixed price contract. The award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded non-set-aside procurement. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $2,587.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot-Ped 11.25 mg kits, with an ultimate completion date of August 6, 2025. This non-set-aside award reflects a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lupron Depot-PED 11.25 mg 3-month formulation, with a ceiling value of $19,073.66. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran...
- The Defense Logistics Agency awarded a $23,165.02 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Lupron Depot-Ped 11.25 mg kits. The contract is unclassified as a set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $65,364.83 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-competitive set-aside award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSF16Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,577.09 to AmerisourceBergen Drug Corp for Lupron Depot-Ped 11.25 mg, a three-month supply of leuprolide acetate used in pediatric endocrinology. This firm fixed-price delivery order, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be sourced from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate operations as one of the nation's largest pharmaceutical distributors serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's substantial $999.999 billion prime IDC with DLA Troop Support Medical (SPE2DX), which operates through December 2026 and provides comprehensive global pharmaceutical support to military healthcare programs and the Defense Health Agency. The contract vehicle enables rapid procurement of specialized medications across multiple therapeutic domains to support military medical readiness. AmerisourceBergen's selection reflects its demonstrated capability to fulfill federal pharmaceutical supply requirements and its established role as a critical vendor within the Defense Health Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 8/28/25 |